Advent Life Sciences
Investor profile
Advent Life Sciences has backed 6 European tech companies across 6 funding rounds between 2020 and 2025, joining rounds totalling €218M. Most active in Healthtech. Data as of Nov 2026.
Deals
6
distinct rounds
Companies
6
backed
Active span
2020–2025
6 yrs
Total round €
€218M
sum of rounds joined
Deals by year
distinct rounds / yearAdvent Life Sciences — deals by year — interactive chart.
Data table
| Advent Life Sciences — deals by year | |
|---|---|
| 2020 | 1 |
| 2022 | 4 |
| 2025 | 1 |
Top sectors
by dealsAdvent Life Sciences — top sectors — interactive chart.
Data table
| Advent Life Sciences — top sectors | |
|---|---|
| Healthtech | 6 |
Stages
by dealsAdvent Life Sciences — stages — interactive chart.
Data table
| Advent Life Sciences — stages | |
|---|---|
| Other | 2 |
| Seed | 1 |
| Series A | 1 |
| Series B | 1 |
| Series C | 1 |
Countries
by dealsAdvent Life Sciences — countries — interactive chart.
Data table
| Advent Life Sciences — countries | |
|---|---|
| UK | 5 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Morningside Ventures2
- AdBio partners1
- BGF1
- Bioqube Ventures1
- Bpifrance1
- British Business Bank1
- British Patient Capital1
- Cambridge Innovation Capital1
- Cowen Healthcare Investments1
- CTI Life Sciences1
- Emerson Collective1
- EQT Life Sciences1
- Fonds de solidarité FTQ1
- Forbion1
- Harrington Discovery Institute1
- Minderoo Foundation1
- Mubadala Capital1
- Novateur Ventures1
- Novo Holdings1
- Sofinnova Partners1
- SoftBank1
- Swiss VC Pureos Bioventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Proximie | UK | 1 | €77M |
| F2G | UK | 1 | €69M |
| Cyted Health | UK | 1 | €37M |
| Tridek-One | France | 1 | €16M |
| Epitopea | UK | 1 | €12M |
| Amphista Therapeutics | UK | 1 | €6.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Proximie | Series C | €77M | 2022-06 |
| F2G | Other | €69M | 2022-08 |
| Cyted Health | Series B | €37M | 2025-09 |
| Tridek-One | Other | €16M | 2022-09 |
| Epitopea | Seed | €12M | 2022-04 |
| Amphista Therapeutics | Series A | €6.7M | 2020-07 |